Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Laboratory Corp of America Holdings (LH)

Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,893,536
  • Shares Outstanding, K 83,639
  • Annual Sales, $ 12,162 M
  • Annual Income, $ 418,000 K
  • EBIT $ 1,302 M
  • EBITDA $ 1,879 M
  • 60-Month Beta 1.05
  • Price/Sales 1.62
  • Price/Cash Flow 11.62
  • Price/Book 2.42

Options Overview Details

View History
  • Implied Volatility 19.92% ( +1.35%)
  • Historical Volatility 22.30%
  • IV Percentile 25%
  • IV Rank 21.56%
  • IV High 33.61% on 10/23/24
  • IV Low 16.16% on 11/29/23
  • Put/Call Vol Ratio 1.42
  • Today's Volume 46
  • Volume Avg (30-Day) 544
  • Put/Call OI Ratio 0.95
  • Today's Open Interest 4,700
  • Open Int (30-Day) 7,450

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 3.40
  • Number of Estimates 9
  • High Estimate 3.48
  • Low Estimate 3.32
  • Prior Year 3.30
  • Growth Rate Est. (year over year) +3.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
212.45 +12.37%
on 10/22/24
247.99 -3.74%
on 11/11/24
+24.59 (+11.48%)
since 10/21/24
3-Month
211.28 +12.99%
on 10/08/24
247.99 -3.74%
on 11/11/24
+9.89 (+4.32%)
since 08/21/24
52-Week
191.97 +24.35%
on 05/31/24
247.99 -3.74%
on 11/11/24
+26.35 (+12.41%)
since 11/21/23

Most Recent Stories

More News
Labcorp: Q3 Earnings Snapshot

Labcorp: Q3 Earnings Snapshot

LH : 239.25 (+0.59%)
What to Expect From Labcorp Holdings' Q3 2024 Earnings Report

With Labcorp Holdings gearing up to release its third-quarter earnings later this month, analysts expect single-digit earnings growth.

XLV : 143.97 (+0.76%)
$SPX : 5,949.22 (+0.54%)
LH : 239.25 (+0.59%)
How Is Labcorp Holdings’ Stock Performance Compared to Other Healthcare Stocks?

Labcorp Holdings recently outperformed the healthcare sector peers, and Wall Street analysts are moderately optimistic about the stock’s prospects.

XHS : 93.43 (+0.46%)
DGX : 163.13 (+1.12%)
LH : 239.25 (+0.59%)
Are Wall Street Analysts Bullish on Labcorp Holdings Stock?

Labcorp Holdings has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.

LH : 239.25 (+0.59%)
$SPX : 5,949.22 (+0.54%)
$SPX : 5,949.22 (+0.54%)
XLV : 143.97 (+0.76%)
UBS : 31.80 (-0.09%)
Labcorp: Q2 Earnings Snapshot

Labcorp: Q2 Earnings Snapshot

LH : 239.25 (+0.59%)
Here’s What to Expect From Labcorp Holdings’ Next Earnings Report

With Labcorp Holdings gearing up to release its second-quarter earnings results next month, analysts project a double-digit earnings growth.

LH : 239.25 (+0.59%)
$SPX : 5,949.22 (+0.54%)
XLV : 143.97 (+0.76%)
Stocks Finish Higher on Solid Q1 Earnings Results

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.36%. US stock indexes...

$SPX : 5,949.22 (+0.54%)
SPY : 593.61 (+0.53%)
$DOWI : 43,938.53 (+1.22%)
DIA : 439.70 (+1.25%)
$IUXX : 20,748.27 (+0.39%)
QQQ : 504.81 (+0.33%)
ZNZ24 : 109-200 (-0.06%)
TSLA : 343.00 (+0.28%)
BA : 144.04 (-1.40%)
ALB : 109.10 (-0.41%)
DPZ : 448.78 (+2.23%)
HTLF : 66.71 (+2.94%)
Strong Q1 Earnings and Lower Bond Yields Boost Stocks

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.24%. US stock indexes this morning...

$SPX : 5,949.22 (+0.54%)
SPY : 593.61 (+0.53%)
$DOWI : 43,938.53 (+1.22%)
DIA : 439.70 (+1.25%)
$IUXX : 20,748.27 (+0.39%)
QQQ : 504.81 (+0.33%)
ZNZ24 : 109-200 (-0.06%)
TSLA : 343.00 (+0.28%)
ALB : 109.10 (-0.41%)
PARA : 10.85 (+2.55%)
DPZ : 448.78 (+2.23%)
HTLF : 66.71 (+2.94%)
Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today

The company's first quarter as a separate entity was better than anticipated.

LH : 239.25 (+0.59%)
FTRE : 19.71 (+2.92%)
October 2023 Cash Secured Puts Trades Update #2

Small and large dividend stock and ETF investors can use covered calls and puts trades to generate monthly income from options premiums and options trading.

DOW : 44.95 (+2.32%)
JEPI : 59.91 (+0.72%)
PFE : 25.20 (+1.04%)
VZ : 42.53 (+0.73%)
MSFT : 415.04 (+0.09%)
V : 310.42 (+0.99%)
LH : 239.25 (+0.59%)
NEM : 43.12 (+0.30%)
DHR : 233.50 (+0.17%)
CAT : 390.49 (+2.36%)
XOM : 121.69 (+1.14%)
ISRG : 549.92 (+1.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients...

See More

Key Turning Points

3rd Resistance Point 242.89
2nd Resistance Point 240.78
1st Resistance Point 239.32
Last Price 239.25
1st Support Level 235.75
2nd Support Level 233.64
3rd Support Level 232.18

See More

52-Week High 247.99
Last Price 239.25
Fibonacci 61.8% 226.59
Fibonacci 50% 219.98
Fibonacci 38.2% 213.37
52-Week Low 191.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar